Skip to content

Clinical trials

Observational Brain Injuries, Traumatic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Injuries, Traumatic Phase: Observational Country / region: Italy Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20131
20141
20161
20172
20182
20201
20212
20221
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status5
Not yet recruiting2
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Azienda Ospedaliera San Gerardo di Monza2
University of Milano Bicocca2
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1
Azienda Usl di Bologna1
Catholic University, Italy1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva1
IRCCS Eugenio Medea1
IRCCS Istituto delle Scienze Neurologiche di Bologna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Injuries, Traumatic20
Subarachnoid Hemorrhage5
Cerebral Hemorrhage2
Intracranial Hypertension2
Ischemic Stroke2
Stroke2
Wounds and Injuries2
Ataxia1
Cognitive Dysfunction1
Coma1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.